Join the Durvalumab group to help and get support from people like you.
Durvalumab News (Page 2)
AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer
May 1, 2017 – AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi...
Further information
Related condition support groups
Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Endometrial Cancer, Hepatocellular Carcinoma